John J McGuire Selected Research

PAR-2 Receptor

1/2021	Activation of protease-activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome.
4/2017	Age-related changes to vascular protease-activated receptor 2 in metabolic syndrome: a relationship between oxidative stress, receptor expression, and endothelium-dependent vasodilation.
1/2017	Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome.
3/2016	[Role/function of protease-activated receptor 2 on vascular endothelium in metabolic syndrome].
1/2016	Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.
1/2015	Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.
10/2014	Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndrome.
2/2010	Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats.
12/2004	Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2.
1/2004	Proteinase-activated Receptor 2 (PAR2): a challenging new target for treatment of vascular diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John J McGuire Research Topics

Disease

10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 10/2014
7	Neoplasms (Cancer) 11/2005 - 04/2002
3	Inflammation (Inflammations) 01/2017 - 02/2010
3	Leukemia 12/2006 - 01/2003
2	Body Weight (Weight, Body) 12/2017 - 01/2010
2	Obesity 01/2017 - 01/2016
2	Stroke (Strokes) 02/2010 - 05/2007
2	Hypertension (High Blood Pressure) 10/2008 - 07/2007
1	Proteinuria 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Cerebral Hemorrhage 02/2010
1	Vascular System Injuries 02/2010
1	Edema (Dropsy) 02/2010
1	Hypertensive Encephalopathy 02/2010
1	Rheumatoid Arthritis 04/2009
1	Hemorrhagic Stroke 05/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005
1	Hypotension (Low Blood Pressure) 12/2004
1	Vascular Diseases (Vascular Disease) 01/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2003
1	Colonic Neoplasms (Colon Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

10	PAR-2 ReceptorIBA 01/2021 - 01/2004
5	Folic Acid AntagonistsIBA 04/2009 - 05/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 12/2004
4	Folic Acid (Vitamin M)FDA LinkGeneric 04/2009 - 05/2002
4	pyrimidineIBA 11/2005 - 04/2002
3	Vasodilator Agents (Vasodilators)IBA 01/2021 - 07/2007
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2003
3	BradykininIBA 02/2010 - 05/2007
3	CarbonIBA 12/2006 - 12/2004
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 07/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2015 - 05/2007
2	EnzymesIBA 04/2009 - 05/2002
2	Angiotensin IIIBA 10/2008 - 05/2007
2	folylpolyglutamate synthetaseIBA 10/2005 - 05/2002
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Angiotensin II Type 1 Receptor BlockersIBA 10/2019
1	azilsartanIBA 10/2019
1	Methacholine Chloride (Methacholine)FDA Link 01/2019
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2019
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	ApelinIBA 12/2018
1	Dihydrotachysterol (AT 10)IBA 12/2017
1	Cyclic GMPIBA 04/2017
1	2-furoyl-LIGRLO-amideIBA 04/2017
1	CytokinesIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2014
1	2,5-dichloro-4-bromophenol (B 2)IBA 02/2010
1	CarbenoxoloneIBA 02/2010
1	CalciumIBA 02/2010
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2010
1	LipidsIBA 01/2010
1	Messenger RNA (mRNA)IBA 01/2010
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2009
1	AcidsIBA 04/2009
1	Thymidylate SynthaseIBA 04/2009
1	Hydroxymethyl and Formyl TransferasesIBA 04/2009
1	purineIBA 04/2009
1	SaltsIBA 10/2008
1	Losartan (Cozaar)FDA LinkGeneric 05/2007
1	Captopril (Capoten)FDA LinkGeneric 05/2007
1	Calcimycin (A23187)IBA 05/2007
1	Bridged-Ring CompoundsIBA 12/2006
1	AICA ribonucleotide (ZMP)IBA 04/2006
1	thymidylate synthase-dihydrofolate reductaseIBA 11/2005
1	Protein Isoforms (Isoforms)IBA 10/2005
1	Pemetrexed (MTA)FDA Link 12/2004
1	ProstaglandinsIBA 12/2004
1	Indicators and Reagents (Reagents)IBA 12/2003
1	AminopterinIBA 01/2003
1	raltitrexed (D 1694)IBA 01/2003
1	6-methylprednisolone-21-hemisuberate N,N,N'-triethylenediamine amideIBA 01/2003
1	Glutamic Acid (Glutamate)FDA Link 05/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2009
1	Drug Therapy (Chemotherapy) 05/2002